Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?

Area of Science:

• Nephrology
• Transplantation Immunology
• Urology

Background:

• Hyperuricemia is a frequent complication in renal transplant recipients.
• Uric acid (UA) may influence renal dysfunction after transplantation.
• Chronic allograft nephropathy (CAN) is a significant concern in long-term graft survival.

Purpose of the Study:

• To investigate the association between serum uric acid (UA) levels and the development of chronic allograft nephropathy (CAN).
• To evaluate the prevalence of hyperuricemia in renal transplant recipients over a three-year follow-up period.

Main Methods:

• A cohort of 133 renal transplant recipients was followed for three years.
• Serum UA levels were measured within the first month and annually thereafter.
• CAN diagnosis and graft failure were recorded; Cox regression analysis was used to assess UA's impact.

Main Results:

• The prevalence of hyperuricemia increased significantly from 55.3% at one month to 84.6% at three years post-transplant (P<.001).
• CAN was diagnosed in 31.5% of patients, with 52% experiencing graft failure.
• Cox regression analysis revealed no significant association between UA levels and the development of CAN (P>.05).

Conclusions:

• Hyperuricemia is highly prevalent in renal transplant recipients.
• Serum UA levels did not demonstrate a significant effect on the development of CAN within the first three years after transplantation.
• Further research may be needed to explore the long-term role of UA in renal allograft outcomes.